Please provide your email address to receive an email when new articles are posted on . At 52 weeks, MASH resolution without worsening of fibrosis was reported among 36% on denifanstat vs. 13% on ...
Multicenter Randomized Trial of Adjuvant Fluorouracil and Folinic Acid Compared With Surgery Alone After Resection of Colorectal Liver Metastases: FFCD ACHBTH AURC 9002 Trial From a cohort of 303 ...
A new study brings researchers closer to better understanding the pathology of the fatty liver disease MASH, which stands for metabolic dysfunction-associated steatohepatitis. MASH is a consequence of ...
Zdenek Hel, Ph.D., a professor in the UAB Department of Pathology’s Division of Molecular and Cellular Pathology, received a five-year, $3.6 million R01 to support his project, “Dysregulated ...
Shannon Bailey, Ph.D., Professor, Molecular and Cellular Pathology, Chair, UAB Institutional Animal Care and Use Committee (IACUC), has been awarded an R01 grant funding her research on circadian and ...
Niigata, Japan – The research group of Professor Kamimura in Niigata University have demonstrated the complementary role of peripheral and central nervous system on GH–IGF-1axis activation to prevent ...
(A) scRNA-seq with ST can reveal spatial zonation profiles of gene expression in the normal liver and a detailed cell landscape of the human liver, showing that 50% of liver genes have partitioning ...
Preoperative chemotherapy for colorectal liver metastases (CLM) can produce histologic changes in the nontumor-bearing liver (NTBL) that may impact on surgical outcomes. Patients and Methods From a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results